The newly rebranded Bioventure Healthcare plans to expand the production capacity of its manufacturing plant by introducing new products such as oral solid tablets, capsules and sachets lines by 2023.
GHH’s healthcare portfolio includes biopharma, manufacturing, medical supply chain, hospital and clinic management, healthcare technology, and occupational health an.